Sara Montemerani

Sara Montemerani


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
CLCristian Lazzari
Cristian Lazzari
SMSara Montemerani
Sara Montemerani
CFCosimo Fabrizi
Cosimo Fabrizi
CSCecilia Sacchi
Cecilia Sacchi
ABAntoine BELPERIO
Antoine BELPERIO
SNSimone Nocentini
Simone Nocentini
Background: Thanks to the evolution of laboratory medicine, point-of-care testing (POCT) for troponin levels in the blood (hs-cTn) has been greatly improved in order to quickly diagnose acute myocardial infarction (AMI) with an accuracy similar to standard laboratory tests. The rationale of the HEART POCT study is to propose the application of the 0/1 h European Society of Cardiology (ESC) algorithm in the pre-hospital setting using a POCT device (Atellica VTLi). Methods: This is a prospective study comparing patients who underwent pre-hospital point-of-care troponin testing (Atellica VTLi) with a control group that underwent standard hospital-based troponin testing (Elecsys). The primary objectives were to determine if the 0/1 h algorithm of the Atellica VTLi is non-inferior to the standard laboratory method for diagnosing AMI and to analyze rule-out/rule-in times and emergency department (ED) stay times. The secondary objective was to evaluate the feasibility of pre-hospital troponin testing. Results: The Atellica VTLi demonstrated reasonable sensitivity for detecting AMI, with sensitivity increasing from 60% at the first measurement (time 0) to 80% at the second measurement (time 1 h). Both the Atellica VTLi and the Elecsys method showed high negative predictive value (NPV), indicating that a negative troponin result effectively ruled out AMI in most cases. Patients in the Atellica VTLi group experienced significantly shorter times to diagnosis and discharge from the emergency department compared to the control group (Elecsys). This highlights a potential benefit of point-of-care testing: streamlining the diagnostic and treatment processes. Conclusions: POCT allows for rapid troponin measurement, leading to a faster diagnosis of non-ST-segment elevation myocardial infarction (NSTEMI). This enables earlier initiation of appropriate treatment, potentially improving patient outcomes and the efficiency of emergency department operations. POCT could be particularly beneficial in pre-hospital settings, enabling faster triage and transportation of patients to appropriate care centers.

1 January 2023 in Open Access Emergency Medicine
Verified
Journal Article
Open access
PDF file
MMMaria Lucia Mosso
Maria Lucia Mosso
SMSara Montemerani
Sara Montemerani
Purpose: Chest pain in a common symptom in patients attending Emergency Department worldwide and can be related to an extensive variety of disorders, so it represents a diagnostic and logistic challenge for Emergency physicians. The aim of this study is to identify a subgroup of patients with a low pre-test probability of major adverse cardiac events, for which there is no need of troponin testing, to avoid potential harm from false-positive testing and long length stay in ED. Patients and Methods: We retrospectively analyzed data of patients that attended ED of Siena complaining chest pain from January 2019 to August 2021. We used a modified HEART score, only evaluating history, EKG, age and risk factors. A 0– 1 HEAR score was considered at very low risk for adverse cardiac events. Sensitivity, specificity, PPV, NPV and incidence of adverse cardiac events were calculated. The accuracy of HEAR score was evaluated with ROC curve. The correlation of adverse cardiac events with HEAR score 0– 1 was evaluated with Fisher test. Results: In this study, we included 2046 patients, of which 279 were classified at very low risk. The incidence of adverse cardiac events in this population was 0.36%. Sensibility was 97.5%, sensitivity 61%, PPV 36.8%, NPV 99.1%. The AUC for global accuracy of HEAR score was 0.945. Chi-square’s P value for the association between adverse cardiac events and HEAR score 0– 1 was < 0.001. Conclusion: The draft presented in this study answers to the necessity to make a personalized path for patients attending ED with chest pain. The choice to avoid troponin testing may appear risky, but data from this study and from other similar show that a careful evaluation of clinical data and EKG allows to correctly discriminate which patients will not have adverse cardiac events, reducing the length of stay in ED.

1 December 2024 in Open Access Emergency Medicine
Verified
Journal Article
Open access
PDF file
SMSara Montemerani
Sara Montemerani
CFCosimo Fabrizi
Cosimo Fabrizi
CSCecilia Sacchi
Cecilia Sacchi
ABAntoine Belperio
Antoine Belperio
LMLorenzo Moriani
Lorenzo Moriani
SNSimone Nocentini
Simone Nocentini
Purpose: Mild Traumatic brain injury is classified based on Glasgow Coma Scale (GCS 13– 15), it also involves transient alteration of brain function, which may lead to severe short- and long-term sequelae. When treating a patient with a mild head injury outside the hospital, it is of crucial importance to decide whether to transport him to a center without neurosurgery or to a center equipped with neurosurgery (primary centralization). Recent decades have seen exploration of portable, non-invasive devices for intracranial injury and stroke detection, with microwave frequency electromagnetic field technology showing promising clinical outcomes. This clinical investigation aims to assess the diagnostic accuracy of the TES HT100 medical device, utilizing electromagnetic fields for endocranial lesion screening. Patients and Methods: Patients with mild traumatic brain injury were randomly enrolled according to inclusion criteria. Twenty-three patients recruited from the Intensive Short-Term Observation (ISTO) unit at San Donato Hospital in Arezzo. The sensitivity and specificity of the TES HT were evaluated statistically against cranial computed tomography (CT), the gold standard. Results: A preliminary analysis shows a sensitivity of 100% and a specificity of 100%. Based on these results, there is maximum concordance between the two examinations, and the AUC is 1. No adverse events related to the use of TES HT100 or the examination. Conclusion: The device’s ability to differentiate patients with intracranial lesions from those without can streamline the diagnostic and therapeutic process, potentially leading to improved patient outcomes. If Temnography will maintain high standards of sensitivity and specificity with the expansion of the enrolled population, it could be considered as a stable screening tool in the Emergency Room (ER). We could think to apply this technology to reduce the length of stay that patients with mTBI have to spend in ER for observation. Temnography could also be useful in special categories of patients such as pregnant women or the pediatric population. Moreover, another front of future development of this technology could be extending the study to include Territorial Emergency. In this context, Temnography could aid centralized decision-making in patient care.

17 June 2020 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
SMSara Montemerani
Sara Montemerani
VDValeria Donati
Valeria Donati
NPNicola Di Pietra
Nicola Di Pietra
GIGiovanni Iannelli
Giovanni Iannelli
Dyspnoea is defined as a subjective perception of laboured breathing. It is a common cause of access to the emergency department (ED), it has a high rate of intensive care unit admission and a high mortality. The most common causes of dyspnoea in the adult include pneumonia, heart failure, chronic obstructive pulmonary disease, pulmonary embolism and asthma. Due to the high variety of dyspnoea’s causes, the need for a rapid and accurate diagnosis puts the emergency physician in trouble. Moreover, standard tests such as chest radiography, B-type natriuretic peptide and d-dimer require time and may be less useful in patients with respiratory failure who require urgent therapy. Point-of-care ultrasound (POCUS) is rapid, non-invasive, repeatable and a useful tool in evaluating patients with acute and severe dyspnoea. This case report demonstrates the usefulness of POCUS in a patient with undifferentiated respiratory failure presenting to the ED.

11 October 2024 in Emergency Care Journal
Verified
Journal Article
Open access
PDF file
FPFederica Piazzai
Federica Piazzai
GMGilda Morelli
Gilda Morelli
LBLorenzo Barone
Lorenzo Barone
MCManuel Carli
Manuel Carli
CBChiara Borchi
Chiara Borchi
SMSara Montemerani
Sara Montemerani
The EFAST technique is a rapid ultrasound method introduced into ATLS guidelines since 2006 for the evaluation of trauma patients. It allows for the detection of free fluid in the abdomen, pericardial tamponade, and pneumothorax within 2 to 3 minutes without impacting management times in pre-hospital settings. Recently, the EFAST-PS protocol has been introduced, which includes an additional scan of the pubic symphysis to identify “open book” pelvic fractures. This mini review examines the efficacy of the EFAST-PS protocol in pre-hospital environments through a literature review and analysis of a clinical case. It is demonstrated that EFAST has high specificity and sensitivity in detecting free fluid in abdominal and thoracic recesses, improving the management of trauma patients and reducing time to definitive intervention. The addition of the pubic symphysis scan did not cause any issues but increased safety in managing patients with suspected fractures and hemodynamic instability. Emergency ultrasound assessment, including the EFAST-PS protocol, should be integrated into the overall clinical picture to provide useful data for the decision-making process.

24 August 2021 in Research Square
Verified
Preprint
Open access
PDF file
SMSara Montemerani
Sara Montemerani
AUAsia Urbanelli
Asia Urbanelli
SCSilvia Cini
Silvia Cini
GSGiovanni Sbrana
Giovanni Sbrana
TTThomas Tori
Thomas Tori
FSFernando Schiraldi
Fernando Schiraldi
IntroductionArterial blood gas (ABG) is a useful diagnostic test in the emergency setting. Thanks to the evolution of miniaturized technologies, it was possible to produce a Point of Care ABG analyzer that extended the use of blood gas analysis even in an out-of-hospital context. In the beginning of 2020, the Emergency Medical Service (EMS) of USL Toscana Sud-Est introduced a Point of Care ABG analyzer to characterize respiratory failure in pre-hospital. The onset of SARS-CoV-2 pandemic made the testing ground much more challenging. However, this situation highlighted the potential utility of the hand-held ABG analyzer for a better identification of silent hypoxemia in SARS-CoV-2 patients in pre-hospital setting.Methods Primary endpoint Early identification of cases of silent hypoxemia in pre-hospital setting. In our retrospective observational analysis, we want to understand how many patients with silent hypoxemia the hand-held analyzer detect respect the standard measure of peripherical oxygen saturation (SpO2) at rest with pulse oximeter or respect the 6 minutes walking test. Design and setting We performed a retrospective descriptive analysis of 48 consecutive SARS-CoV-2 patients who activated the territorial Emergency Medical Service of Arezzo (USL Toscana Sud-Est). We included patients between October and November 2020. Age < 18 and pregnancy were considered exclusion criteria. After the telephone triage, the operations center sent the ALS ambulance with a team made up of a physician and a nurse who performed a clinical evaluation of the patient and an arterial blood gas analysis directly at home. Arterial blood was collected from the patient's radial or brachial artery. ALS team directly visualized the result of the exam on EPOC.ResultsA total of 48 SARS-CoV-2 patients were collected, 28 men and 20 women, respectively. Nineteen of the total amounts of 48 SARS-CoV-2 patients had silent hypoxemia identified with the hospital ABG analyzer (gold standard). They didn’t refer dyspnea or didn’t show increased work of breathing during clinical evaluation. These patients had an arterial blood gas oxygen tension (PaO2) of less than 60 mmHg. EPOC identified 20 cases of silent hypoxemia instead of the 19 identified with the hospital blood gas analyzer (Sensibility 100%, Specificity 97%, VPP 95%, VPN 100% with 95% CI). The pulse oximeter detected 21 cases of silent hypoxemia (Sensibility 100%, Specificity 94%, VPP 89%, VPN 100% with 95% CI). The 6 minutes walking test detected only 11 of the 19 cases of silent hypoxemia because the test was aborted in 5 cases, and it was not performed in other 3 cases.ConclusionFrom this first descriptive analysis, we conclude that hand-held blood gas analyzer is useful in the early identification of silent hypoxemia in COVID-19 patients. The EPOC system is a handheld and wireless solution that provides accurate results in less than one minute after sample introduction at the patient’s side. The portability of this point-of-care tool make it potentially useful in pre-hospital clinical practice.